Abstract
Patients with locally advanced esophageal cancer are treated with definitive chemoradiation (dCXRT) for a number of reasons. Some patients are never referred to a surgeon for a con-versation about surgery, others decline surgery, and some are not candidates for surgery due to a sag in performance status secondary to therapy. Regardless of method of arrival at dCXRT, the risk of local/regional recurrence during follow-up is significant. Many of these patients are faced with limited options for therapy once dCXRT has failed. Salvage esoph-agectomy has historically been considered a morbid procedure and poor choice for local/ regional recurrence. This chapter reviews the recent literature arguing the relevance of salvage resection. We recommend that any patient suffering from persistent or recurrent lo-cal/regional only disease after dCXRT should be referred to an experienced esophageal center to consider surgical options.
Original language | English (US) |
---|---|
Pages (from-to) | S341-S349 |
Journal | Journal of Thoracic Disease |
Volume | 6 |
Issue number | SUPPL.3 |
DOIs | |
State | Published - 2014 |
Keywords
- Definitive chemoradiation (dCXRT)
- Esophageal cancer
- Salvage
- Selective
- Surgery
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine